Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 August 2021 | Story Dr Cindé Greyling | Photo Supplied
Dr Samantha Potgieter – in the front line of the fight against COVID-19 .


Dr Samantha Potgieter is an infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State (UFS). She was also the first health-care worker to receive the Johnson & Johnson vaccine in the Free State. Prior to the COVID-19 pandemic, her main focus was on complicated HIV and drug-resistant TB as well as hospital-acquired infections. Since the emergence of COVID-19, she has been managing the COVID-19 clinical response at Universitas.

What is the best thing about your job?
I work in an amazing team with colleagues who, after 14 years, I can say have become friends.

What is the best and worst decision you have ever made?
Marrying the person that I did is by far the best decision I have ever made. And I must be honest, I regret very few of my decisions. Even the bad ones have turned out to be learning opportunities.

What was/is the biggest challenge of your career?
Navigating the COVID-19 pandemic as an infectious disease physician was by far the biggest challenge of my career. It was an equally fascinating learning curve and an immense privilege to be in a position to contribute.

What does the word woman mean to you?
The word woman means a million different things. We are daughters, wives, mothers, sisters, and friends. We are strong when we need to be and yet vulnerable with those we love. We can be powerful but kind. I love being a woman.

Which woman inspires you, and why?
My mom. She is hands down the kindest person I know. Her quiet strength and her grace – she is everything I strive to be.

What advice would you give to the 15-year-old you?
I spent a lot of time wondering what life is all about, and I still don’t have the answers. But I think I would tell the 15-year-old me to remember that life doesn’t have to be perfect or easy in order to be good.

What is the one self-care thing that you do? 
Cuddling my little ones – it’s my very favourite thing to do.

What makes you a woman of quality, impact, and care?
I am a woman, and I think all women are these things. We all have the capacity to care for those around us and to change our small corner of the earth for the better.
 
I cannot live without … my tribe of sisters, they make me laugh, they hold me up.
My secret weapon is … an early start to the day.
I always have … an extremely messy car (it’s really not my fault)
I will never … buy a pressure cooker – a good friend has put the fear of life into me!
I hope … that my daughter will grow up in a world where she will also be able to say that she loves being a woman.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept